<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35571609</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1875-8630</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>2022</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Disease markers</Title>
          <ISOAbbreviation>Dis Markers</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Progress in Endoscopic and Interventional Treatment of Esophagogastric Variceal Bleeding.</ArticleTitle>
        <Pagination>
          <StartPage>2940578</StartPage>
          <MedlinePgn>2940578</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">2940578</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/2940578</ELocationID>
        <Abstract>
          <AbstractText>Esophagogastric variceal bleeding (EGVB) is one of the main complications of portal hypertension, especially in patients with liver cirrhosis, and has a very high fatality rate. At present, the treatment methods for rupture and bleeding of gastroesophageal varices (GV) include drug therapy, compression hemostasis with three-lumen and two-balloon tube, endoscopic therapy, and interventional and surgical operations. Endoscopy and intervention or their combined application is the mainstream treatment modes in clinical practice, especially their combined application has been increasingly recognized by front-line clinicians. This article intends to discuss the application characteristics of the two treatment methods.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Bin Liu and Gang Li.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Bin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Shandong First Medical University, Taian 271000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Gang</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0002-8739-2785</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Vascular Surgery, The Second Affiliated Hospital of Shandong First Medical University, Taian 271000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Dis Markers</MedlineTA>
        <NlmUniqueID>8604127</NlmUniqueID>
        <ISSNLinking>0278-0240</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004724" MajorTopicYN="N">Endoscopy</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004932" MajorTopicYN="Y">Esophageal and Gastric Varices</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006975" MajorTopicYN="Y">Hypertension, Portal</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014648" MajorTopicYN="Y">Varicose Veins</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>We declare no conflict of interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>4</Hour>
          <Minute>2</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35571609</ArticleId>
        <ArticleId IdType="pmc">PMC9106506</ArticleId>
        <ArticleId IdType="doi">10.1155/2022/2940578</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Tantai X., Liu Y., Yeo Y. H., et al.  Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. 
Journal of Hepatology
. 2022;76(3):588–599. doi: 10.1016/j.jhep.2021.11.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2021.11.006</ArticleId>
            <ArticleId IdType="pubmed">34785325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshiji H., Nagoshi S., Akahane T., et al.  Evidence-based clinical practice guidelines for liver cirrhosis 2020. 
Journal of Gastroenterology
. 2021;56(7):593–619. doi: 10.1007/s00535-021-01788-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00535-021-01788-x</ArticleId>
            <ArticleId IdType="pmc">PMC8280040</ArticleId>
            <ArticleId IdType="pubmed">34231046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kezer C. A., Gupta N. The role of therapeutic endoscopy in patients with cirrhosis-related causes of gastrointestinal bleeding. 
Current Gastroenterology Reports
. 2018;20(7):p. 31. doi: 10.1007/s11894-018-0637-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11894-018-0637-6</ArticleId>
            <ArticleId IdType="pubmed">29886513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Franchis R. Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. 
Journal of Hepatology
. 2005;43(1):167–176. doi: 10.1016/j.jhep.2005.05.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2005.05.009</ArticleId>
            <ArticleId IdType="pubmed">15925423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ziqin S. Endoscopic treatment of esophagogastric varices bleeding. 
Modern Digestive and Interventional Diagnosis and Treatment
. 2013;18(1):27–29.</Citation>
        </Reference>
        <Reference>
          <Citation>Hui D., Wu C., He C., Gang L., Nan C. New progress in endoscopic hemostasis treatment of esophageal and gastric variceal bleeding with portal hypertension in liver cirrhosis [J] 
China Practical Medicine
. 2011;6(19):82–83.</Citation>
        </Reference>
        <Reference>
          <Citation>Yuyong T., Meixian L., Deliang L. Optimized application of sclerosing agents in the prevention and treatment of esophageal variceal bleeding in liver cirrhosis. 
Chinese Journal of Gastrointestinal Endoscopy
. 2020;7(1):39–42.</Citation>
        </Reference>
        <Reference>
          <Citation>Li X., Jiang T., Gao J. Endoscopic variceal ligation combined with argon plasma coagulation versus ligation alone for the secondary prophylaxis of variceal bleeding: a systematic review and meta-analysis. 
European Journal of Gastroenterology &amp; Hepatology
. 2017;29(6):621–628. doi: 10.1097/MEG.0000000000000861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MEG.0000000000000861</ArticleId>
            <ArticleId IdType="pubmed">28195875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spleen and Portal Hypertension Surgery Group of Surgery Branch of Chinese Medical Association. Expert consensus on diagnosis and treatment of esophageal and gastric variceal bleeding in patients with liver cirrhosis and portal hypertension 2019 edition. 
Chinese Journal of Digestive Surgery
. 2019;18(12):1087–1093.</Citation>
        </Reference>
        <Reference>
          <Citation>Chinese Society of Hepatology. Guidelines for the prevention and treatment of esophagogastric variceal hemorrhage in cirrhotic portal hypertension. 
Chinese Journal of Internal Medicine
. 2016;55(1):57–72.</Citation>
        </Reference>
        <Reference>
          <Citation>Tian X., Shi Y., Hu J., Wang G., Zhang C. Percutaneous transhepatic variceal embolization with cyanoacrylate vs. transjugular intrahepatic portal systematic shunt for esophageal variceal bleeding. 
Hepatology International
. 2013;7(2):636–644. doi: 10.1007/s12072-013-9433-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12072-013-9433-4</ArticleId>
            <ArticleId IdType="pubmed">26201796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan X., Zhang K., Han X., et al.  Comparison of percutaneous transhepatic variceal embolization (PTVE) followed by partial splenic embolization versus PTVE alone for the treatment of acute esophagogastric variceal massive hemorrhage. 
Journal of Vascular and Interventional Radiology
. 2014;25(12):1858–1865. doi: 10.1016/j.jvir.2014.08.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jvir.2014.08.019</ArticleId>
            <ArticleId IdType="pubmed">25311969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Triantafyllou M., Stanley A. J. Update on gastric varices. 
World Journal of Gastrointestinal Endoscopy
. 2014;6(5):168–175. doi: 10.4253/wjge.v6.i5.168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4253/wjge.v6.i5.168</ArticleId>
            <ArticleId IdType="pmc">PMC4024489</ArticleId>
            <ArticleId IdType="pubmed">24891929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H. L., Lu W. J., Zhang Y. L., et al.  Comparison of transjugular intrahepatic portosystemic shunt in the treatment of cirrhosis with or without portal vein thrombosis: a retrospective study. 
Frontiers in Medicine
. 2021;8, article 737984 doi: 10.3389/fmed.2021.737984.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2021.737984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tatsumi A., Maekawa S., Osawa L., et al.  Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliteration. 
JGH Open
. 2022;6(2):139–147. doi: 10.1002/jgh3.12712.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jgh3.12712</ArticleId>
            <ArticleId IdType="pmc">PMC8829100</ArticleId>
            <ArticleId IdType="pubmed">35155824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olson E., Yune H. Y., Klatte E. C. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. 
AJR. American Journal of Roentgenology
. 1984;143(3):627–628. doi: 10.2214/ajr.143.3.627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.143.3.627</ArticleId>
            <ArticleId IdType="pubmed">6331747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi Y. H., Yoon C. J., Park J. H., Chung J. W., Kwon J. W., Choi G. M. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. 
Korean Journal of Radiology
. 2003;4(2):109–116. doi: 10.3348/kjr.2003.4.2.109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3348/kjr.2003.4.2.109</ArticleId>
            <ArticleId IdType="pmc">PMC2698068</ArticleId>
            <ArticleId IdType="pubmed">12845306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong C. H., Kim H. J., Park J. H., et al.  Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. 
Journal of Gastroenterology and Hepatology
. 2009;24(3):372–378. doi: 10.1111/j.1440-1746.2008.05651.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1746.2008.05651.x</ArticleId>
            <ArticleId IdType="pubmed">19032446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang S. Y., Kim G. H., Park S. Y., et al.  Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study. 
Clinical and Molecular Hepatology
. 2012;18(4):368–374. doi: 10.3350/cmh.2012.18.4.368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3350/cmh.2012.18.4.368</ArticleId>
            <ArticleId IdType="pmc">PMC3540373</ArticleId>
            <ArticleId IdType="pubmed">23323252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho S. K., Shin S. W., Lee I. H., Do YS C. S. W., Park K. B., Yoo B. C. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. 
AJR. American Journal of Roentgenology
. 2007;189(6):W365–W372. doi: 10.2214/AJR.07.2266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.07.2266</ArticleId>
            <ArticleId IdType="pubmed">18029851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu H., Zheng C., Liang B., Xiong B. Quantitative splenic embolization possible: application of 8Spheres conformal microspheres in partial splenic embolization (PSE) 
BMC Gastroenterology
. 2021;21(1):p. 407. doi: 10.1186/s12876-021-01991-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12876-021-01991-3</ArticleId>
            <ArticleId IdType="pmc">PMC8555096</ArticleId>
            <ArticleId IdType="pubmed">34706678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z., Zhou H., Zhou K., Tu J., Xu B. An underlying softening mechanism in pale, soft and exudative - like rabbit meat: the role of reactive oxygen species - generating systems. 
Food Research International
. 2022;151, article 110853 doi: 10.1016/j.foodres.2021.110853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.foodres.2021.110853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniai N., Onda M., Tajiri T., Toba M., Yoshida H. Endoscopic variceal ligation (EVL) combined with partial splenic embolization (PSE) 
Hepato-Gastroenterology
. 1999;46(29):2849–2853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10576359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohmoto K., Yamamoto S. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia. 
Hepato-Gastroenterology
. 2003;50(54):1766–1769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14696400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murata K., Shiraki K., Takase K., Nakano T., Tameda Y. Long term follow-up for patients with liver cirrhosis after partial splenic embolization. 
Hepato-Gastroenterology
. 1996;43(11):1212–1217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8908553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao S., She H. T., Lu Y., Shi J. L. Splenic embolization combined with double-mirror method in treatment of cirrhosis with hypersplenism of advanced schistosomiasis patients: a report of 38 cases. 
Turkish Neurosurgery
. 2022;32(2):176–184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34936076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim N. H., Kim H. J., Cho Y. K., Hong H. P., Kim B. I. Long-term efficacy and safety of partial splenic embolization in hepatocellular carcinoma patients with thrombocytopenia who underwent transarterial chemoembolization. 
Journal of Korean Medical Science
. 2019;34(30, article e208) doi: 10.3346/jkms.2019.34.e208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3346/jkms.2019.34.e208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talwar A., Knight G., Al Asadi A., et al.  Post-embolization outcomes of splenic artery pseudoaneurysms: a single-center experience. 
Clinical Imaging
. 2021;80:160–166. doi: 10.1016/j.clinimag.2021.07.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinimag.2021.07.007</ArticleId>
            <ArticleId IdType="pubmed">34332465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xuejian L., Enshan L., Youping M., Zhang C. Clinical study of combined interventional embolization in the treatment of portal hypertension. 
Chinese Journal of General Surgery
. 2008;1:70–74.</Citation>
        </Reference>
        <Reference>
          <Citation>Gong W. D., Xue K., Chu Y. K., et al.  Percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization for the treatment of variceal bleeding and hypersplenism. 
International Journal of Clinical and Experimental Medicine
. 2015;8(10):19642–19651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4694528</ArticleId>
            <ArticleId IdType="pubmed">26770628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu R. Y., Liu B., Lin N. Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension. 
World Journal of Gastroenterology
. 2004;10(7):1072–1074. doi: 10.3748/wjg.v10.i7.1072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v10.i7.1072</ArticleId>
            <ArticleId IdType="pmc">PMC4717103</ArticleId>
            <ArticleId IdType="pubmed">15052697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaitoun M. M. A., Basha M. A. A., Elsayed S. B., et al.  Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes. 
Insights Into Imaging
. 2021;12(1):p. 85. doi: 10.1186/s13244-021-01030-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13244-021-01030-5</ArticleId>
            <ArticleId IdType="pmc">PMC8236018</ArticleId>
            <ArticleId IdType="pubmed">34173891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heyman S. N., Rosen S., Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. 
Clinical Journal of the American Society of Nephrology
. 2008;3(1):288–296. doi: 10.2215/CJN.02600607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2215/CJN.02600607</ArticleId>
            <ArticleId IdType="pubmed">18057308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helaly A. Z., Al-Warraky M. S., El-Azab G. I., Kohla M. A., Abdelaal E. E. Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism. 
APMIS
. 2015;123(12):1032–1039. doi: 10.1111/apm.12470.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apm.12470</ArticleId>
            <ArticleId IdType="pubmed">26547369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J., Meng J., Yang M., et al.  Two-step complete splenic artery embolization for the management of symptomatic sinistral portal hypertension. 
Scandinavian Journal of Gastroenterology
. 2022;57(1):78–84. doi: 10.1080/00365521.2021.1983641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00365521.2021.1983641</ArticleId>
            <ArticleId IdType="pubmed">34581650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogawa S., Yamamoto A., Jogo A., et al.  Splenic vein diameter is a risk factor for the portal venous system thrombosis after partial splenic artery embolization. 
Cardiovascular and Interventional Radiology
. 2021;44(6):921–930. doi: 10.1007/s00270-020-02751-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00270-020-02751-8</ArticleId>
            <ArticleId IdType="pmc">PMC8172394</ArticleId>
            <ArticleId IdType="pubmed">33474605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chengen W., Chengjian S., Yanhua W., Tonghui L., Lingling X., Weichao R. Observation of curative effect of releasable balloon in the treatment of portal hypertension and hypersplenism [J] 
Chinese Journal of Hepatology
. 2015;23(6):433–436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26236929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García-Pagán J. C., Saffo S., Mandorfer M., Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? 
Chemosphere
. 2021;273, article 128971 doi: 10.1016/j.jhepr.2020.100122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhepr.2020.100122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chau T. N., Patch D., Chan Y. W., Nagral A., Dick R., Burroughs A. K. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. 
Gastroenterology
. 1998;114(5):981–987. doi: 10.1016/S0016-5085(98)00640-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0016-5085(98)00640-4</ArticleId>
            <ArticleId IdType="pubmed">9558287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tripathi D., Therapondos G., Jackson E., Redhead D. N., Hayes P. C. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. 
Gut
. 2002;51(2):270–274. doi: 10.1136/gut.51.2.270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.51.2.270</ArticleId>
            <ArticleId IdType="pmc">PMC1773295</ArticleId>
            <ArticleId IdType="pubmed">12117893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahadeva S., Bellamy M. C., Kessel D., Davies M. H., Millson C. E. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. 
The American Journal of Gastroenterology
. 2003;98(12):2688–2693. doi: 10.1111/j.1572-0241.2003.08769.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1572-0241.2003.08769.x</ArticleId>
            <ArticleId IdType="pubmed">14687818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halabi S. A., Sawas T., Sadat B., et al.  Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials. 
Journal of Gastroenterology and Hepatology
. 2016;31(9):1519–1526. doi: 10.1111/jgh.13303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jgh.13303</ArticleId>
            <ArticleId IdType="pubmed">26858143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo G. H., Liang H. L., Chen W. C., et al.  A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. 
Endoscopy
. 2007;39(8):679–685. doi: 10.1055/s-2007-966591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-966591</ArticleId>
            <ArticleId IdType="pubmed">17661241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hussain I., Wong Y. J., Lohan R., Lin S., Kumar R. Does preemptive transjugular intrahepatic portosystemic shunt improve survival after acute variceal bleeding? Systematic review, meta-analysis, and trial sequential analysis of randomized trials. 
Journal of Gastroenterology and Hepatology
. 2022;37(3):455–463. doi: 10.1111/jgh.15714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jgh.15714</ArticleId>
            <ArticleId IdType="pubmed">34665473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim W. X., Lin A. N., Cheng Y. F., et al.  Portosystemic shunt in pediatric living donor liver transplant. 
Transplantation Proceedings
. 2022;54(2):403–405. doi: 10.1016/j.transproceed.2021.09.072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.transproceed.2021.09.072</ArticleId>
            <ArticleId IdType="pubmed">35022136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun S. H., Eche T., Dorczynski C., et al.  Predicting death or recurrence of portal hypertension symptoms after TIPS procedures. 
European Radiology
. 2022;32(5):3346–3357. doi: 10.1007/s00330-021-08437-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-021-08437-0</ArticleId>
            <ArticleId IdType="pubmed">35015124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicoară-Farcău O., Han G., Rudler M., et al.  Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data. 
Gastroenterology
. 2021;160(1):193–205.e10. doi: 10.1053/j.gastro.2020.09.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2020.09.026</ArticleId>
            <ArticleId IdType="pubmed">32980344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larrey E., Cluzel P., Rudler M., Goumard C., Damais-Thabut D., Allaire M. TIPS for patients with early HCC: a bridge to liver transplantation. 
Clinics and Research in Hepatology and Gastroenterology
. 2021;13, article 101790 doi: 10.1016/j.clinre.2021.101790.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinre.2021.101790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudler M., Cluzel P., Corvec T. L., et al.  Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. 
Oncology Reports
. 2016;36(2):1166–1172. doi: 10.1111/apt.12934.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.12934</ArticleId>
            <ArticleId IdType="pubmed">27373829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buechter M., Kahraman A., Manka P., et al.  Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation. 
PLoS One
. 2017;12(5, article e0177401) doi: 10.1371/journal.pone.0177401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0177401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z. G., Li Z., Yang Y., et al.  Hemodynamic effect through a novel endoscopic intervention in management of varices and hypersplenism (with video) 
Gastrointestinal Endoscopy
. 2022;95(1):172–183. doi: 10.1016/j.gie.2021.06.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gie.2021.06.029</ArticleId>
            <ArticleId IdType="pubmed">34224735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun X., Zhang A., Zhou T., et al.  Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial. 
Hepatology International
. 2021;15(3):741–752. doi: 10.1007/s12072-021-10155-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12072-021-10155-0</ArticleId>
            <ArticleId IdType="pmc">PMC8286949</ArticleId>
            <ArticleId IdType="pubmed">33638769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Q., Li Z., Yang Y., et al.  Partial splenic embolization through endoscopic ultrasound-guided implantation of coil as a potential technique to treat portal hypertension. 
Endoscopy
. 2021;53(2):E40–E41. doi: 10.1055/a-1174-5590.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/a-1174-5590</ArticleId>
            <ArticleId IdType="pubmed">32483779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishikawa T., Sasaki R., Nishimura T., et al.  A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification. 
Journal of Autism and Developmental Disorders
. 2021;51(7):2229–2240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8189978</ArticleId>
            <ArticleId IdType="pubmed">32926305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-tsao G. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. 
Hepatology
. 2017;65(1):310–335. doi: 10.1002/hep.28906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.28906</ArticleId>
            <ArticleId IdType="pubmed">27786365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jalan R., Hayes P. C. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. 
Gut
. 2015;64(11):1680–1704. doi: 10.1136/gutjnl-2015-309262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2015-309262</ArticleId>
            <ArticleId IdType="pmc">PMC4680175</ArticleId>
            <ArticleId IdType="pubmed">25887380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. 
Journal of Hepatology
. 2015;63(3):743–752. doi: 10.1016/j.jhep.2015.05.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2015.05.022</ArticleId>
            <ArticleId IdType="pubmed">26047908</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
